These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10417434

  • 1. Macrolide immunosuppressants.
    Mrowietz U.
    Eur J Dermatol; 1999; 9(5):346-51. PubMed ID: 10417434
    [Abstract] [Full Text] [Related]

  • 2. The macrolide immunosuppressants in dermatology: mechanisms of action.
    Marsland AM, Griffiths CE.
    Eur J Dermatol; 2002; 12(6):618-22. PubMed ID: 12459545
    [Abstract] [Full Text] [Related]

  • 3. Safety of the new macrolide immunomodulators.
    Robinson N, Singri P, Gordon KB.
    Semin Cutan Med Surg; 2001 Dec; 20(4):242-9. PubMed ID: 11770911
    [Abstract] [Full Text] [Related]

  • 4. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E, Burgdorf WH, Wollenberg A.
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [Abstract] [Full Text] [Related]

  • 5. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135
    [Abstract] [Full Text] [Related]

  • 6. [Pimecrolimus (SDZ ASM 981). Current state of research].
    Dissemond J, Goos M, Wagner SN.
    Dtsch Med Wochenschr; 2002 May 31; 127(22):1199-203. PubMed ID: 12035117
    [No Abstract] [Full Text] [Related]

  • 7. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
    Wolff K.
    Skin Therapy Lett; 2005 Oct 31; 10(8):1-6. PubMed ID: 16292456
    [Abstract] [Full Text] [Related]

  • 8. Systemic ciclosporin and tacrolimus in dermatology.
    Madan V, Griffiths CE.
    Dermatol Ther; 2007 Oct 31; 20(4):239-50. PubMed ID: 17970889
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic potential of macrolide immunosuppressants in dermatology.
    Marsland AM, Griffiths CE.
    Expert Opin Investig Drugs; 2004 Feb 31; 13(2):125-37. PubMed ID: 14996647
    [Abstract] [Full Text] [Related]

  • 15. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G, Sułowicz W, Paczek L.
    Przegl Lek; 2002 Feb 31; 59(11):907-11. PubMed ID: 12715720
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.
    Bornhövd EC, Burgdorf WH, Wollenberg A.
    Curr Opin Investig Drugs; 2002 May 31; 3(5):708-12. PubMed ID: 12090543
    [Abstract] [Full Text] [Related]

  • 18. Topical pimecrolimus in the treatment of seborrheic dermatitis.
    Brownell I, Quan LT, Hsu S.
    Dermatol Online J; 2003 Aug 31; 9(3):13. PubMed ID: 12952760
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.